Lupin signs distribution agreements in key EU territories for orphan drug NaMuscla®
03 juin 2020 01h00 HE
|
Lupin Ltd
Lupin signs distribution agreements in key EU territories for orphan drug NaMuscla®Enables expanded patient access of rare disease medicine to treat myotonia symptoms in non-dystrophic myotonic...